Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lung

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Dautel, Sydney E ^a   Kyle, Jennifer E ^a   Clair, Geremy ^a   Sontag, Ryan L ^a   Weitz, Karl K ^a   Shukla, Anil K ^a   Nguyen, Son N ^a   Kim, Young Mo ^a   Zink, Erika M ^a   Luders, Teresa ^a   Frevert, Charles W ^b   Gharib, Sina A ^b   Laskin, Julia ^b   Carson, James P ^c   Metz, Thomas O ^a   Corley, Richard A ^a   Ansong, Charles ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; SPHINGOLIPID;

ANIMAL; APOPTOSIS; C57BL MOUSE; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; LIPID METABOLISM; LUNG; LUNG ALVEOLUS; METABOLISM; METABOLOME; METABOLOMICS; NEWBORN; PATHOLOGY; PROCEDURES;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; FATTY ACIDS; INFLAMMATION; LIPID METABOLISM; LUNG; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MICE, INBRED C57BL; PULMONARY ALVEOLI; SPHINGOLIPIDS;

EID: 85011396908     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40555     Document Type: Article

References (70)

1. Howson, C. P., Kinney, M. V., McDougall, L. & Lawn, J. E. Born too soon: preterm birth matters. Reprod. Health 10, S1 (2013).
2. Slattery, M. M. & Morrison, J. J. Preterm delivery. Lancet 360, 1489-1497 (2002).
3. Patel, R. M. et al. Causes and Timing of Death in Extremely Premature Infants from 2000 through 2011. N. Engl. J. Med. 372, 331-340 (2015).
4. Bhattacharya, S. & Mariani, T. J. Systems biology approaches to identify developmental bases for lung diseases. Pediatr. Res. 73, 514-22 (2013).
5. Telenga, E. D. et al. Untargeted Lipidomic Analysis in Chronic Obstructive Pulmonary Disease. Uncovering Sphingolipids. Am. J. Respir. Crit. Care Med. 190, 155-164 (2014).
6. Griese, M. et al. Surfactant Lipidomics in Healthy Children and Childhood Interstitial Lung Disease. PLoS One 10, e0117985 (2015).
7. Veldhuizen, R., Nag, K., Orgeig, S. & Possmayer, F. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta 1408, 90-108 (1998).
8. Freedman, S. D. et al. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr mice. Proc Natl Acad Sci 96, 13995-14000 (1999).
9. Hakomori, S. Tumor Malignancy Defined by Aberrant Glycosylation and Sphingo(glyco)lipid Metabolism. Cancer Res. 56, 5309-5318 (1996).
10. Yoder, M. et al. Bioactive Lysophosphatidylcholine 16:0 and 18:0 Are Elevated in Lungs of Asthmatic Subjects. Allergy Asthma Immunol Res 6, 61-65 (2014).
11. Diamond, D. L. et al. Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics. PLoS Pathog. 6, e1000719 (2010).
12. Tisoncik-Go, J. et al. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. Cell Host Microbe 19, 254-266 (2016).
13. Mund, S. I., Stampanoni, M. & Schittny, J. C. Developmental Alveolarization of the Mouse Lung. 237, 2108-2116 (2008).
14. Schulz, M. H. et al. Reconstructing dynamic microRNA-regulated interaction networks. Proc. Natl. Acad. Sci. USA 110, 15686-91 (2013).
15. Coman, C. et al. Simultaneous Metabolite, Protein, Lipid Extraction (SIMPLEX): A Combinatorial Multimolecular Omics Approach for Systems Biology. Mol. Cell. Proteomics 15, 1453-1466 (2016).
16. Cajka, T. & Fiehn, O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt. Chem. 61, 192-206 (2014).
17. Thakur, S. S. et al. Deep and highly sensitive proteome coverage by LC-MS/MS without prefractionation. Mol. Cell. Proteomics 10, M110.003699 (2011).
18. Herzog, R. et al. A novel informatics concept for high-Throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol. 12, R8 (2011).
19. Postle, A. D., Heeley, E. L. & Wilton, D. C. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp. Biochem. Physiol.-A Mol. Integr. Physiol. 129, 65-73 (2001).
20. Grösch, S., Schiffmann, S. & Geisslinger, G. Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50-62 (2012).
21. Uhlig, S. & Gulbins, E. Sphingolipids in the lungs. Am. J. Respir. Crit. Care Med. 178, 1100-1114 (2008).
22. Lee, J. et al. Sphingolipids as cell fate regulators in lung development and disease. Apoptosis 20, 740-757 (2015).
23. Tibboel, J., Reiss, I., De Jongste, J. C. & Post, M. Sphingolipids in lung growth and repair. Chest 145, 120-128 (2014).
24. Spassieva, S. D. et al. Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochem J 424, 273-283 (2015).
25. Medler, T. R. et al. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. Am. J. Respir. Cell Mol. Biol. 38, 639-646 (2008).
26. An, S., Zheng, Y. & Bleu, T. Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J. Biol. Chem. 275, 288-296 (2000).
27. Natarajan, V. et al. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am. J. Respir. Cell Mol. Biol. 49, 6-17 (2013).
28. Singleton, P. A., Dudek, S. M., Chiang, E. T. & Garcia, J. G. N. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and a-Actinin. FASEB J 19, 1646-56 (2005).
29. Tringali, C. et al. Silencing of membrane-Associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Cell Death Differ. 16, 164-174 (2009).
30. Watanabe, R. et al. Ganglioside G M3 Overexpression Induces Apoptosis and Reduces Malignant Potential in Murine Bladder Cancer Ganglioside G M3 Overexpression Induces Apoptosis and Reduces Malignant. Cancer Res 62, 3850-3854 (2002).
31. Chipuk, J. E. et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988-1000 (2012).
32. Bruce, M. C., Honaker, C. E. & Cross, R. J. Lung Fibroblasts Undergo Apoptosis Following Alveolarization. Am. J. Respir. Cell Mol. Biol 20, 228-236 (1999).
33. McGowan, S. E. & McCoy, D. M. Fibroblasts expressing PDGF-receptor-Alpha diminish during alveolar septal thinning in mice. Pediatr. Res. 70, 44-49 (2011).
34. Kresch, M. J., Christian, C., Wu, F. & Hussain, N. Ontogeny of Apoptosis during Lung Development. Pediatr. Res. 43, 426-431 (1998).
35. Calder, P. C. Omega-3 fatty acids and inflammatory processes. Nutrients 2, 355-374 (2010).
36. Duvall, M. G. & Levy, B. D. DHA-And EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur. J. Pharmacol. 1-12, doi: 10.1016/j.ejphar.2015.11.001 (2015).
37. Shimizu, T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49, 123-150 (2009).
38. Kohli, P. & Levy, B. D. Resolvins and protectins: Mediating solutions to inflammation. Br. J. Pharmacol. 158, 960-971 (2009).
39. Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Nat Rev Immunol 8, 349-361 (2008).
40. Hayakawa, M. et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268, 11290-5 (1993).
41. Zhuge, Y. et al. Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1. Allergy, Asthma Immunol. Res. 6, 66-74 (2014).
42. Asaoka, Y., Oka, M., Yoshida, K. & Nishizuka, Y. Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation. Biochem. Biophys. Res. Commun. 178, 1378-1385 (1991).
43. Qin, X., Qiu, C. & Zhao, L. Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation. Cell. Immunol. 289, 185-190 (2014).
44. Liu-Wu, Y., Hurt-Camejo, E. & Wiklund, O. Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis 137, 351-357 (1998).
45. Takeshita, S. et al. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J Atheroscler Thromb 7, 238-246 (2000).
46. Zou, Y. et al. Upregulation of endothelial adhesion molecules by lysophosphatidylcholine: Involvement of G protein-coupled receptor GPR4. FEBS J. 274, 2573-2584 (2007).
47. Niewoehner, D. E., Rice, K., Sinha, A. A. & Wangensteen, D. Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium. J. Appl. Physiol. 63, 1979-1986 (1987).
48. Grossmann, G. et al. Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. J. Appl. Physiol. 86, 633-640 (1999).
49. Braverman, N. E. & Moser, A. B. Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 1822, 1442-1452 (2012).
50. Sindelar, P. J., Guan, Z., Dallner, G. & Ernster, L. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26, 318-324 (1999).
51. Rustow, B. et al. Synthesis and secretion of plasmalogens by type-lI pneumocytes. Biochem J 302, 665-668 (1994).
52. Papamandjaris, a a., MacDougall, D. E. & Jones, P. J. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 62, 1203-1215 (1998).
53. Wu, P. Y. et al. Medium-chain triglycerides in infant formulas and their relation to plasma ketone body concentrations. Pediatr Res 20, 338-341 (1986).
54. Marten, B., Pfeuffer, M. & Schrezenmeir, J. Medium-chain triglycerides. Int. Dairy J. 16, 1374-1382 (2006).
55. Beis, A. Activities of enzymes of ketone body metabolism in liver and muscle tissues of suckling rabbits. Comp. Biochem. Physiol. 81B, 245-249 (1985).
56. Yeh, Y. & Sheehan, P. Preferential utilization of ketone bodies in the brain and lung of newborn rats. Fed Proc 44, 2352-8 (1985).
57. Folch, J., Lees, M. & Sloane Stanley, G. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509 (1987).
58. Nakayasu, E. et al. MPLEx: A robust and universal protocol for single sample integrative proteomic, metabolomic and lipidomic analyses. mSystems (2016).
59. Gao, X. et al. A reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profiling. Anal. Bioanal. Chem. 402, 2923-2933 (2012).
60. Pluskal, T., Castillo, S., Villar-Briones, A. & Oresic, M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11, 395 (2010).
61. Fahy, E. et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 50, Suppl, S9-14 (2009).
62. Fahy, E. et al. A comprehensive classification system for lipids. J. Lipid Res. 46, 839-861 (2005).
63. Wang, Y. et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics 11, 2019-2026 (2011).
64. Kim, S. & Pevzner, P. a. MS-GF+ makes progress towards a universal database search tool for proteomics. Nat. Commun. 5, 5277 (2014).
65. Monroe, M. E., Shawa, J. L., Dalya, D. S., Adkins, J. N. & Richard, S. D. MASIC: A software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput Biol Chem. 32, 215-217 (2008).
66. Kim, Y. M. et al. Diel metabolomics analysis of a hot spring chlorophototrophic microbial mat leads to new hypotheses of community member metabolisms. Front. Microbiol. 6 (2015).
67. Kind, T. et al. FiehnLib-mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal. Chem. 81, 10038-10048 (2009).
68. González, I., Cao, K.-A. L., Davis, M. J. & Déjean, S. Visualising associations between paired omics data sets. BioData Min. 5, 19 (2012).
69. Lanekoff, I. et al. Automated Platform for High-Resolution Tissue Imaging Using Nanospray Desorption Electrospray Ionization Mass Spectrometry. Anal. Chem. (Washington, DC, US) 84, 8351-8356 (2012).
70. Thomas, M. et al. Visualization of high resolution spatial mass spectrometric data during acquisition. Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBS 5545-5548, doi: 10.1109/EMBC.2012.6347250 (2012).